Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Inflammation is correlated with severity and outcome of cerebral venous thrombosis
Liyan Wang1, Jiangang Duan2, Tingting Bian1
1Neurosurgery Department of Xuanwu Hospital Capital Medical University, Changchun st 45, Xicheng District, Beijing, China.
Insights
Inflammation markers are elevated in cerebral venous thrombosis (CVT) and correlate with disease severity and poor outcomes. Neutrophil-to-lymphocyte ratio (NLR) predicts worse prognosis in CVT patients.
Area of Science:
- Neurology
- Immunology
- Vascular Medicine
Background:
- Cerebral venous thrombosis (CVT) is a rare condition with limited understanding of its inflammatory underpinnings.
- Previous studies suggest a potential link between inflammation and CVT, but detailed analysis across disease stages is lacking.
Purpose of the Study:
- To investigate inflammatory changes in peripheral blood and cerebrospinal fluid (CSF) at different stages of CVT.
- To explore the correlation between inflammatory markers, CVT severity, and short-term outcomes.
Main Methods:
- Retrospective analysis of 95 CVT patients and 41 controls.
- Measurement of hypersensitive C-reactive protein (Hs-CRP), interleukin-6 (IL-6), neutrophil-to-lymphocyte ratio (NLR), and immunoglobulins (IgA, IgM, IgG) in blood and CSF.
- Assessment of CVT severity using modified Rankin Scale (mRS), National Institutes of Health Stroke Scale (NIHSS), and other clinical parameters.
Main Results:
- Elevated inflammatory markers (Hs-CRP, IL-6, NLR, IgA, IgM, IgG) were observed in CVT patients compared to controls.
- Inflammatory markers were highest in acute/subacute stages and decreased in the chronic stage.
- Serum NLR and CSF IgM correlated with baseline disability; Hs-CRP correlated with seizures. NLR, CSF IgA, IgM, and IgG associated with NIHSS scores.
- Baseline NLR predicted poor short-term outcomes, with NLR ≥ 4.205 indicating high risk.
Conclusions:
- Inflammation appears to be a consequence of CVT, diminishing over time.
- Inflammatory markers are significantly associated with disease severity upon admission and predict poor short-term outcomes in CVT.
Background:
Few studies have suggested a relationship between inflammation and cerebral venous thrombosis (CVT). This retrospective study aimed to explore the changes in inflammation in different CVT stages and the correlation between inflammation and severity and outcome of CVT.
Methods:
In total, 95 suitable patients with CVT and 41 controls were compared. Patients with CVT were divided into three groups. The inflammatory factors studied included hypersensitive C-reactive protein (Hs-CRP), interleukin-6 (IL-6), and neutrophil-to-lymphocyte ratio (NLR) in the peripheral blood and immunoglobulin A (IgA), immunoglobulin M (IgM), and immunoglobulin G (IgG) in the cerebrospinal fluid (CSF). The severity of CVT was evaluated with the modified Rankin Scale (mRS), the National Institutes of Health Stroke Scale (NIHSS), fundus condition, intracranial pressure (ICP), and complications on admission. The short-term outcome was evaluated with the mRS at discharge.
Results:
The following results were obtained: (1) Inflammatory factor levels in patients with CVT were higher than those in the controls. (2) Inflammatory factor levels in the acute and subacute stages were significantly higher than those in the chronic stage (all P < 0.05). (3) Serum NLR and CSF IgM levels were positively related to baseline degree of disability (odds ratio [OR], 1.279, 95% confidence interval [CI] 1.009-1.621, P = 0.042; OR 1.402, 95% CI 1.036-1.896, P = 0.028). The Hs-CRP level was positively correlated with the baseline occurrence of seizure (OR 1.040, 95% CI 1.001-1.080, P = 0.043). The baseline serum NLR (r = 0.244, P = 0.017), CSF IgA (r = 0.615, P < 0.001), CSF IgM (r = 0.752, P < 0.001), and CSF IgG (r = 0.248, P = 0.015) levels were positively associated with NIHSS. (4) The baseline NLR was significantly associated with high risk of poor outcome at discharge (OR 1.339, 95% CI 1.097-1.784, P = 0.007). Moreover, the ROC showed that NLR ≥ 4.205 could better predict the poor outcome at discharge. The data were analyzed using SPSS.
Conclusions:
Inflammation may develop after CVT and gradually decrease during the course. Inflammation was significantly correlated with severity on admission and short-term poor outcome at discharge in CVT.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Inflammation
Correlations

